Abstract:The in vitro dissolution mechanism of an amorphous solid dispersion (ASD) remains elusive and highly individualized, yet rational design of ASDs with optimal performance and prediction of their in vitro/in vivo performance are very much desirable in the pharmaceutical industry. To this end, we carried out comprehensive investigation of various ASD systems of griseofulvin, felodipine, and ketoconazole, in PVP-VA or HPMC-AS at different drug loading. Physiochemical properties and processes related to drug-polymer-water interaction, including the drug crystallization tendency in aqueous medium, drug-polymer interaction before and after moisture exposure, supersaturation of drug in the presence of polymer, polymer dissolution kinetics, etc., were characterized and correlated with the dissolution performance of ASDs at different dose and different drug/polymer ratio. It was observed that ketoconazole/HPMC-AS ASD outperformed all other ASDs in various dissolution conditions, which was attributed to the drugs low crystallization tendency, the strong ketoconazole/HPMC-AS interaction and the robustness of this interaction against water disruption, the dissolution rate and the availability of HPMC-AS in solution, and the ability of HPMC-AS in maintaining ketoconazole supersaturation. It was demonstrated that all these properties have implications for the dissolution performance of various ASD systems, and further quantification of them could be used as potential predictors for in vitro dissolution of ASDs. For all ASDs investigated, HPMC-AS systems performed better than, or at least comparably with, their PVP-VA counterparts, regardless of the drug loading or dose. This observation cannot be solely attributed to the ability of HPMC-AS in maintaining drug supersaturation. We also conclude that, for fast crystallizers without strong drug-polymer interaction, the only feasible option to improve dissolution might be to lower the dose and the drug loading in the ASD. In this study, we implemented an ASD/water Flory-Huggins parameter plot, which might assist in revealing the physical nature of the drug-polymer interaction. We also introduced supersaturation parameter and dissolution performance parameter as two quantitative measurements to compare the abilities of polymers in maintaining drug supersaturation, and the dissolution performance of various solid dispersions, respectively.

A novel thermodynamic strategy for predicting influence of relative humidity on stability of amorphous solid dispersions

Thermodynamic Mechanism of Physical Stability of Amorphous Pharmaceutical Formulations

Influence of humidity on the phase behavior of API/polymer formulations

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation

Viscoelastic Behavior of Supercooled and Glassy ASDs at Humid Conditions Can Be Predicted

Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory.

Influence of Excipients on Thermodynamic Phase Behavior of Pharmaceutical/solvent Systems: Molecular Thermodynamic Model Prediction

A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions

Role of Polymers in the Physical and Chemical Stability of Amorphous Solid Dispersion: A Case Study of Carbamazepine.

Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects

Influence Mechanism of Drug-Polymer Compatibility on Humidity Stability of Crystalline Solid Dispersion

Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs)

Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions

Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Influence of copolymer composition on the phase behavior of solid dispersions.

Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.

Evaluate the Ability of PVP to Inhibit Crystallization of Amorphous Solid Dispersions by Density Functional Theory and Experimental Verify.

Thermodynamic Phase Behavior of API/Polymer Solid Dispersions

Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients